 | This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Homatropine" – news ·newspapers ·books ·scholar ·JSTOR(October 2021) (Learn how and when to remove this message) |
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a601006 |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.001.561 |
| Chemical and physical data | |
| Formula | C16H21NO3 |
| Molar mass | 275.348 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Homatropine (Equipin,Isopto Homatropine) is ananticholinergicmedication that is an antagonist atmuscarinic acetylcholine receptors and thus theparasympathetic nervous system. It is used ineye drops as acycloplegic (to temporarily paralyzeaccommodation), and as amydriatic (to dilate thepupil).
The related chemical compoundhomatropine methylbromide (methylhomatropine) is a different medication. Homatropine is lesspotent thanatropine and has a shorter duration of action. It is available as thehydrobromidesalt. Homatropine is also given as an atropine substitute,[1] given to reverse the muscarinic andCNS effects associated with indirectcholinomimetic (anti-AChase) administration.
Homatropine hydrobromide is on theWorld Health Organization's List of Essential Medicines.[2]
It is an antagonist of all five muscarinic acetylcholine receptors.[3]
 | Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it. |